Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Inspiration, ideas and insights for growth companies: View Resource Center >
Summit Partners
Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Back to Companies

Companies

Viroclinics Biosciences

Viroclinics Biosciences is a leading provider of specialized clinical and non-clinical services to the global virology therapeutics and vaccine development market. The company offers a full range of services to support and accelerate the market entry of new drugs, vaccines and antivirals from discovery to launch.

RELATED NEWS
Portfolio News portfolio news icon Created using Figma
December 16, 2021

Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Cl...

Cerba Healthcare to Acquire Viroclinics-DDL
Insights & Interests insights icon

Healthcare Trends: How Viroclinics-DDL is Accelerating the Development of Antiviral Thera...

Summit Partners Viroclinics
Summit Partners Viroclinics
 
www.viroclinics.com
Location:
Rotterdam, The Netherlands
Leadership:

Davide Molho

Founded in:
2001
invested in:
2019
Status:

Acquired by Cerba Healthcare 2022

Summit Team:
Luke Parsons Thomas M. Tarnowski
Portfolio News portfolio news icon Created using Figma
December 16, 2021

Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Cl...

Cerba Healthcare to Acquire Viroclinics-DDL
Insights & Interests insights icon
July 01, 2021

Healthcare Trends: How Viroclinics-DDL is Accelerating the Development of Antiviral Thera...

Summit Partners Viroclinics
Portfolio News portfolio news icon Created using Figma
July 20, 2020

Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer

Davide Molho Summit Partners Viroclinics
Summit News Artboard 1
March 03, 2020

Summit Partners Announces Growth Equity Investment in Viroclinics Biosciences

Viroclinics Summit Partners
Growth Equity for Exceptional Companies
    • © 2023 Summit Partners. All rights reserved.

    • Privacy
    • Legal Disclosures
    • Sitemap
    • Cookie Settings
    • Contact Summit Partners
    • LP Login
    • Portfolio Company Careers
    • Join Our Newsletter